nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CES2—Irinotecan—lung cancer	0.274	0.477	CbGbCtD
Prasugrel—ALB—lung cancer	0.186	1	CbGaD
Prasugrel—ALB—Gefitinib—lung cancer	0.0336	0.0583	CbGbCtD
Prasugrel—CYP2C19—Gefitinib—lung cancer	0.0218	0.0378	CbGbCtD
Prasugrel—CYP2C19—Teniposide—lung cancer	0.0211	0.0367	CbGbCtD
Prasugrel—ALB—Erlotinib—lung cancer	0.0198	0.0345	CbGbCtD
Prasugrel—CYP2B6—Irinotecan—lung cancer	0.0183	0.0318	CbGbCtD
Prasugrel—CYP2C9—Gefitinib—lung cancer	0.0181	0.0314	CbGbCtD
Prasugrel—ALB—Irinotecan—lung cancer	0.0179	0.0312	CbGbCtD
Prasugrel—CYP2C9—Teniposide—lung cancer	0.0175	0.0305	CbGbCtD
Prasugrel—CYP2B6—Cisplatin—lung cancer	0.0149	0.0259	CbGbCtD
Prasugrel—CYP3A4—Topotecan—lung cancer	0.0115	0.02	CbGbCtD
Prasugrel—CYP3A4—Gefitinib—lung cancer	0.0105	0.0183	CbGbCtD
Prasugrel—CYP3A4—Teniposide—lung cancer	0.0102	0.0177	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—lung cancer	0.00999	0.0174	CbGbCtD
Prasugrel—CYP2C9—Paclitaxel—lung cancer	0.00979	0.017	CbGbCtD
Prasugrel—ALB—Methotrexate—lung cancer	0.00948	0.0165	CbGbCtD
Prasugrel—CYP3A4—Vinorelbine—lung cancer	0.0081	0.0141	CbGbCtD
Prasugrel—CYP2C9—Cisplatin—lung cancer	0.00787	0.0137	CbGbCtD
Prasugrel—CYP3A4—Crizotinib—lung cancer	0.00645	0.0112	CbGbCtD
Prasugrel—CYP3A4—Erlotinib—lung cancer	0.00622	0.0108	CbGbCtD
Prasugrel—CYP3A4—Paclitaxel—lung cancer	0.00569	0.0099	CbGbCtD
Prasugrel—CYP3A4—Irinotecan—lung cancer	0.00562	0.00976	CbGbCtD
Prasugrel—CYP3A4—Vinblastine—lung cancer	0.00499	0.00868	CbGbCtD
Prasugrel—CYP3A4—Etoposide—lung cancer	0.0045	0.00782	CbGbCtD
Prasugrel—CYP3A4—Docetaxel—lung cancer	0.00412	0.00715	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—lung cancer	0.00307	0.00533	CbGbCtD
Prasugrel—CES2—mammary gland—lung cancer	0.00179	0.15	CbGeAlD
Prasugrel—P2RY12—epithelium—lung cancer	0.00156	0.131	CbGeAlD
Prasugrel—CES2—respiratory system—lung cancer	0.00119	0.1	CbGeAlD
Prasugrel—ALB—mammary gland—lung cancer	0.00102	0.0859	CbGeAlD
Prasugrel—CES2—bronchus—lung cancer	0.000981	0.0823	CbGeAlD
Prasugrel—CES2—trachea—lung cancer	0.000881	0.0739	CbGeAlD
Prasugrel—CES2—cardiac atrium—lung cancer	0.000828	0.0694	CbGeAlD
Prasugrel—CES2—bone marrow—lung cancer	0.000699	0.0586	CbGeAlD
Prasugrel—CYP2C9—mammary gland—lung cancer	0.000639	0.0536	CbGeAlD
Prasugrel—CES2—lung—lung cancer	0.000633	0.0531	CbGeAlD
Prasugrel—Clopidogrel—ABCB1—lung cancer	0.000504	1	CrCbGaD
Prasugrel—CES2—lymph node—lung cancer	0.000433	0.0363	CbGeAlD
Prasugrel—CYP2B6—respiratory system—lung cancer	0.00043	0.0361	CbGeAlD
Prasugrel—CYP2B6—bronchus—lung cancer	0.000354	0.0297	CbGeAlD
Prasugrel—ALB—lymph node—lung cancer	0.000248	0.0208	CbGeAlD
Prasugrel—CYP2B6—lung—lung cancer	0.000228	0.0192	CbGeAlD
Prasugrel—Nausea—Teniposide—lung cancer	0.000221	0.00175	CcSEcCtD
Prasugrel—Urinary tract disorder—Paclitaxel—lung cancer	0.000221	0.00175	CcSEcCtD
Prasugrel—Hypotension—Vinorelbine—lung cancer	0.000221	0.00175	CcSEcCtD
Prasugrel—Anaemia—Irinotecan—lung cancer	0.00022	0.00175	CcSEcCtD
Prasugrel—Oedema peripheral—Paclitaxel—lung cancer	0.00022	0.00174	CcSEcCtD
Prasugrel—Urethral disorder—Paclitaxel—lung cancer	0.000219	0.00174	CcSEcCtD
Prasugrel—Body temperature increased—Topotecan—lung cancer	0.000218	0.00173	CcSEcCtD
Prasugrel—Body temperature increased—Erlotinib—lung cancer	0.000216	0.00171	CcSEcCtD
Prasugrel—Anaemia—Gemcitabine—lung cancer	0.000215	0.0017	CcSEcCtD
Prasugrel—Leukopenia—Irinotecan—lung cancer	0.000214	0.00169	CcSEcCtD
Prasugrel—Eye disorder—Etoposide—lung cancer	0.000213	0.00169	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—lung cancer	0.000213	0.00169	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—lung cancer	0.000213	0.00169	CcSEcCtD
Prasugrel—Dyspnoea—Vinorelbine—lung cancer	0.00021	0.00167	CcSEcCtD
Prasugrel—Hypersensitivity—Vinblastine—lung cancer	0.000209	0.00166	CcSEcCtD
Prasugrel—Eye disorder—Paclitaxel—lung cancer	0.000209	0.00165	CcSEcCtD
Prasugrel—Cough—Irinotecan—lung cancer	0.000208	0.00165	CcSEcCtD
Prasugrel—Leukopenia—Gemcitabine—lung cancer	0.000208	0.00165	CcSEcCtD
Prasugrel—Angiopathy—Etoposide—lung cancer	0.000207	0.00164	CcSEcCtD
Prasugrel—Hypertension—Irinotecan—lung cancer	0.000206	0.00163	CcSEcCtD
Prasugrel—Immune system disorder—Etoposide—lung cancer	0.000206	0.00163	CcSEcCtD
Prasugrel—Mediastinal disorder—Etoposide—lung cancer	0.000205	0.00163	CcSEcCtD
Prasugrel—Asthenia—Vinblastine—lung cancer	0.000204	0.00161	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000204	0.00161	CcSEcCtD
Prasugrel—Fatigue—Vinorelbine—lung cancer	0.000204	0.00161	CcSEcCtD
Prasugrel—Hypersensitivity—Topotecan—lung cancer	0.000203	0.00161	CcSEcCtD
Prasugrel—Cough—Gemcitabine—lung cancer	0.000203	0.00161	CcSEcCtD
Prasugrel—Angiopathy—Paclitaxel—lung cancer	0.000203	0.00161	CcSEcCtD
Prasugrel—Immune system disorder—Paclitaxel—lung cancer	0.000202	0.0016	CcSEcCtD
Prasugrel—Mediastinal disorder—Paclitaxel—lung cancer	0.000201	0.0016	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—lung cancer	0.000201	0.0016	CcSEcCtD
Prasugrel—Hypertension—Gemcitabine—lung cancer	0.000201	0.00159	CcSEcCtD
Prasugrel—Anaemia—Cisplatin—lung cancer	0.0002	0.00159	CcSEcCtD
Prasugrel—Epistaxis—Docetaxel—lung cancer	0.000199	0.00158	CcSEcCtD
Prasugrel—Asthenia—Topotecan—lung cancer	0.000198	0.00157	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000196	0.00156	CcSEcCtD
Prasugrel—Asthenia—Erlotinib—lung cancer	0.000196	0.00155	CcSEcCtD
Prasugrel—Anaphylactic shock—Irinotecan—lung cancer	0.000195	0.00154	CcSEcCtD
Prasugrel—Diarrhoea—Vinblastine—lung cancer	0.000194	0.00154	CcSEcCtD
Prasugrel—Leukopenia—Cisplatin—lung cancer	0.000194	0.00154	CcSEcCtD
Prasugrel—Back pain—Etoposide—lung cancer	0.000192	0.00152	CcSEcCtD
Prasugrel—Thrombocytopenia—Irinotecan—lung cancer	0.000191	0.00151	CcSEcCtD
Prasugrel—Haemoglobin—Docetaxel—lung cancer	0.00019	0.00151	CcSEcCtD
Prasugrel—Anaphylactic shock—Gemcitabine—lung cancer	0.00019	0.0015	CcSEcCtD
Prasugrel—Haemorrhage—Docetaxel—lung cancer	0.000189	0.0015	CcSEcCtD
Prasugrel—Diarrhoea—Topotecan—lung cancer	0.000189	0.0015	CcSEcCtD
Prasugrel—Back pain—Paclitaxel—lung cancer	0.000188	0.00149	CcSEcCtD
Prasugrel—Dizziness—Vinblastine—lung cancer	0.000188	0.00149	CcSEcCtD
Prasugrel—Urinary tract disorder—Docetaxel—lung cancer	0.000187	0.00148	CcSEcCtD
Prasugrel—Diarrhoea—Erlotinib—lung cancer	0.000187	0.00148	CcSEcCtD
Prasugrel—Body temperature increased—Vinorelbine—lung cancer	0.000187	0.00148	CcSEcCtD
Prasugrel—Oedema peripheral—Docetaxel—lung cancer	0.000187	0.00148	CcSEcCtD
Prasugrel—Urethral disorder—Docetaxel—lung cancer	0.000186	0.00147	CcSEcCtD
Prasugrel—Thrombocytopenia—Gemcitabine—lung cancer	0.000186	0.00147	CcSEcCtD
Prasugrel—Skin disorder—Gemcitabine—lung cancer	0.000184	0.00146	CcSEcCtD
Prasugrel—Anaemia—Etoposide—lung cancer	0.000183	0.00145	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000183	0.00145	CcSEcCtD
Prasugrel—Dizziness—Topotecan—lung cancer	0.000182	0.00145	CcSEcCtD
Prasugrel—Hypotension—Irinotecan—lung cancer	0.000182	0.00144	CcSEcCtD
Prasugrel—Dizziness—Erlotinib—lung cancer	0.000181	0.00143	CcSEcCtD
Prasugrel—Anaemia—Paclitaxel—lung cancer	0.00018	0.00142	CcSEcCtD
Prasugrel—Headache—Vinblastine—lung cancer	0.000178	0.00141	CcSEcCtD
Prasugrel—Angioedema—Paclitaxel—lung cancer	0.000178	0.00141	CcSEcCtD
Prasugrel—Leukopenia—Etoposide—lung cancer	0.000178	0.00141	CcSEcCtD
Prasugrel—Hypotension—Gemcitabine—lung cancer	0.000177	0.0014	CcSEcCtD
Prasugrel—Eye disorder—Docetaxel—lung cancer	0.000177	0.0014	CcSEcCtD
Prasugrel—Anaphylactic shock—Cisplatin—lung cancer	0.000177	0.0014	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—lung cancer	0.000174	0.00138	CcSEcCtD
Prasugrel—Leukopenia—Paclitaxel—lung cancer	0.000174	0.00138	CcSEcCtD
Prasugrel—Rash—Topotecan—lung cancer	0.000174	0.00138	CcSEcCtD
Prasugrel—Hypersensitivity—Vinorelbine—lung cancer	0.000174	0.00138	CcSEcCtD
Prasugrel—Dermatitis—Topotecan—lung cancer	0.000174	0.00138	CcSEcCtD
Prasugrel—Dyspnoea—Irinotecan—lung cancer	0.000174	0.00137	CcSEcCtD
Prasugrel—Cough—Etoposide—lung cancer	0.000173	0.00137	CcSEcCtD
Prasugrel—Thrombocytopenia—Cisplatin—lung cancer	0.000173	0.00137	CcSEcCtD
Prasugrel—Headache—Topotecan—lung cancer	0.000173	0.00137	CcSEcCtD
Prasugrel—Rash—Erlotinib—lung cancer	0.000172	0.00136	CcSEcCtD
Prasugrel—Dermatitis—Erlotinib—lung cancer	0.000172	0.00136	CcSEcCtD
Prasugrel—Angiopathy—Docetaxel—lung cancer	0.000172	0.00136	CcSEcCtD
Prasugrel—Skin disorder—Cisplatin—lung cancer	0.000172	0.00136	CcSEcCtD
Prasugrel—Hypertension—Etoposide—lung cancer	0.000171	0.00136	CcSEcCtD
Prasugrel—Immune system disorder—Docetaxel—lung cancer	0.000171	0.00136	CcSEcCtD
Prasugrel—Headache—Erlotinib—lung cancer	0.000171	0.00135	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000171	0.00135	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—lung cancer	0.000171	0.00135	CcSEcCtD
Prasugrel—Mediastinal disorder—Docetaxel—lung cancer	0.000171	0.00135	CcSEcCtD
Prasugrel—Cough—Paclitaxel—lung cancer	0.00017	0.00134	CcSEcCtD
Prasugrel—Asthenia—Vinorelbine—lung cancer	0.000169	0.00134	CcSEcCtD
Prasugrel—Dyspnoea—Gemcitabine—lung cancer	0.000169	0.00134	CcSEcCtD
Prasugrel—Nausea—Vinblastine—lung cancer	0.000169	0.00134	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Irinotecan—lung cancer	0.000168	0.00133	CcSEcCtD
Prasugrel—Hypertension—Paclitaxel—lung cancer	0.000168	0.00133	CcSEcCtD
Prasugrel—Fatigue—Irinotecan—lung cancer	0.000168	0.00133	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000168	0.00133	CcSEcCtD
Prasugrel—Hypotension—Cisplatin—lung cancer	0.000165	0.00131	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000164	0.0013	CcSEcCtD
Prasugrel—Nausea—Topotecan—lung cancer	0.000164	0.0013	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000164	0.0013	CcSEcCtD
Prasugrel—Fatigue—Gemcitabine—lung cancer	0.000164	0.0013	CcSEcCtD
Prasugrel—Nausea—Erlotinib—lung cancer	0.000162	0.00128	CcSEcCtD
Prasugrel—Anaphylactic shock—Etoposide—lung cancer	0.000162	0.00128	CcSEcCtD
Prasugrel—Diarrhoea—Vinorelbine—lung cancer	0.000162	0.00128	CcSEcCtD
Prasugrel—Back pain—Docetaxel—lung cancer	0.00016	0.00126	CcSEcCtD
Prasugrel—Anaphylactic shock—Paclitaxel—lung cancer	0.000159	0.00126	CcSEcCtD
Prasugrel—Thrombocytopenia—Etoposide—lung cancer	0.000159	0.00126	CcSEcCtD
Prasugrel—Dyspnoea—Cisplatin—lung cancer	0.000158	0.00125	CcSEcCtD
Prasugrel—Skin disorder—Etoposide—lung cancer	0.000157	0.00125	CcSEcCtD
Prasugrel—Dizziness—Vinorelbine—lung cancer	0.000156	0.00124	CcSEcCtD
Prasugrel—Thrombocytopenia—Paclitaxel—lung cancer	0.000155	0.00123	CcSEcCtD
Prasugrel—Skin disorder—Paclitaxel—lung cancer	0.000154	0.00122	CcSEcCtD
Prasugrel—Body temperature increased—Irinotecan—lung cancer	0.000154	0.00122	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Cisplatin—lung cancer	0.000153	0.00121	CcSEcCtD
Prasugrel—Anaemia—Docetaxel—lung cancer	0.000152	0.00121	CcSEcCtD
Prasugrel—Hypotension—Etoposide—lung cancer	0.000151	0.0012	CcSEcCtD
Prasugrel—Body temperature increased—Gemcitabine—lung cancer	0.00015	0.00119	CcSEcCtD
Prasugrel—Rash—Vinorelbine—lung cancer	0.000149	0.00118	CcSEcCtD
Prasugrel—Dermatitis—Vinorelbine—lung cancer	0.000149	0.00118	CcSEcCtD
Prasugrel—Hypotension—Paclitaxel—lung cancer	0.000148	0.00118	CcSEcCtD
Prasugrel—Headache—Vinorelbine—lung cancer	0.000148	0.00117	CcSEcCtD
Prasugrel—Leukopenia—Docetaxel—lung cancer	0.000148	0.00117	CcSEcCtD
Prasugrel—Haematuria—Methotrexate—lung cancer	0.000145	0.00115	CcSEcCtD
Prasugrel—Dyspnoea—Etoposide—lung cancer	0.000144	0.00114	CcSEcCtD
Prasugrel—Cough—Docetaxel—lung cancer	0.000144	0.00114	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—lung cancer	0.000143	0.00114	CcSEcCtD
Prasugrel—Hypersensitivity—Irinotecan—lung cancer	0.000143	0.00114	CcSEcCtD
Prasugrel—Hypertension—Docetaxel—lung cancer	0.000142	0.00113	CcSEcCtD
Prasugrel—Dyspnoea—Paclitaxel—lung cancer	0.000142	0.00112	CcSEcCtD
Prasugrel—Nausea—Vinorelbine—lung cancer	0.00014	0.00111	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Etoposide—lung cancer	0.00014	0.00111	CcSEcCtD
Prasugrel—Body temperature increased—Cisplatin—lung cancer	0.00014	0.00111	CcSEcCtD
Prasugrel—Asthenia—Irinotecan—lung cancer	0.00014	0.00111	CcSEcCtD
Prasugrel—Fatigue—Etoposide—lung cancer	0.00014	0.00111	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000139	0.0011	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—lung cancer	0.000137	0.00109	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000137	0.00109	CcSEcCtD
Prasugrel—Fatigue—Paclitaxel—lung cancer	0.000137	0.00108	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—lung cancer	0.000137	0.00108	CcSEcCtD
Prasugrel—Asthenia—Gemcitabine—lung cancer	0.000136	0.00108	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—lung cancer	0.000135	0.00107	CcSEcCtD
Prasugrel—Anaphylactic shock—Docetaxel—lung cancer	0.000135	0.00107	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—lung cancer	0.000134	0.00106	CcSEcCtD
Prasugrel—Diarrhoea—Irinotecan—lung cancer	0.000133	0.00106	CcSEcCtD
Prasugrel—Thrombocytopenia—Docetaxel—lung cancer	0.000132	0.00104	CcSEcCtD
Prasugrel—Skin disorder—Docetaxel—lung cancer	0.000131	0.00104	CcSEcCtD
Prasugrel—Hypersensitivity—Cisplatin—lung cancer	0.00013	0.00103	CcSEcCtD
Prasugrel—Diarrhoea—Gemcitabine—lung cancer	0.00013	0.00103	CcSEcCtD
Prasugrel—Dizziness—Irinotecan—lung cancer	0.000129	0.00102	CcSEcCtD
Prasugrel—Body temperature increased—Etoposide—lung cancer	0.000128	0.00101	CcSEcCtD
Prasugrel—Eye disorder—Methotrexate—lung cancer	0.000128	0.00101	CcSEcCtD
Prasugrel—Asthenia—Cisplatin—lung cancer	0.000127	0.001	CcSEcCtD
Prasugrel—Hypotension—Docetaxel—lung cancer	0.000126	0.000996	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—lung cancer	0.000126	0.000995	CcSEcCtD
Prasugrel—Body temperature increased—Paclitaxel—lung cancer	0.000126	0.000994	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—lung cancer	0.000124	0.000984	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—lung cancer	0.000124	0.000981	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—lung cancer	0.000123	0.000977	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—lung cancer	0.000123	0.000975	CcSEcCtD
Prasugrel—Rash—Irinotecan—lung cancer	0.000123	0.000972	CcSEcCtD
Prasugrel—Dermatitis—Irinotecan—lung cancer	0.000123	0.000972	CcSEcCtD
Prasugrel—Headache—Irinotecan—lung cancer	0.000122	0.000966	CcSEcCtD
Prasugrel—Diarrhoea—Cisplatin—lung cancer	0.000121	0.000958	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—lung cancer	0.00012	0.000953	CcSEcCtD
Prasugrel—Dyspnoea—Docetaxel—lung cancer	0.00012	0.00095	CcSEcCtD
Prasugrel—Rash—Gemcitabine—lung cancer	0.00012	0.000947	CcSEcCtD
Prasugrel—Dermatitis—Gemcitabine—lung cancer	0.000119	0.000946	CcSEcCtD
Prasugrel—Hypersensitivity—Etoposide—lung cancer	0.000119	0.000945	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—lung cancer	0.000119	0.000941	CcSEcCtD
Prasugrel—Headache—Gemcitabine—lung cancer	0.000119	0.000941	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—lung cancer	0.000118	0.000937	CcSEcCtD
Prasugrel—Hypersensitivity—Paclitaxel—lung cancer	0.000117	0.000927	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—lung cancer	0.000117	0.000925	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—lung cancer	0.000116	0.000923	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Docetaxel—lung cancer	0.000116	0.00092	CcSEcCtD
Prasugrel—Asthenia—Etoposide—lung cancer	0.000116	0.00092	CcSEcCtD
Prasugrel—Fatigue—Docetaxel—lung cancer	0.000116	0.000919	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—lung cancer	0.000116	0.000918	CcSEcCtD
Prasugrel—Nausea—Irinotecan—lung cancer	0.000116	0.000916	CcSEcCtD
Prasugrel—Back pain—Methotrexate—lung cancer	0.000115	0.000911	CcSEcCtD
Prasugrel—Asthenia—Paclitaxel—lung cancer	0.000114	0.000902	CcSEcCtD
Prasugrel—Nausea—Gemcitabine—lung cancer	0.000113	0.000892	CcSEcCtD
Prasugrel—Rash—Cisplatin—lung cancer	0.000111	0.000883	CcSEcCtD
Prasugrel—Dermatitis—Cisplatin—lung cancer	0.000111	0.000882	CcSEcCtD
Prasugrel—Diarrhoea—Etoposide—lung cancer	0.000111	0.000878	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—lung cancer	0.00011	0.000875	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—lung cancer	0.00011	0.00087	CcSEcCtD
Prasugrel—Diarrhoea—Paclitaxel—lung cancer	0.000109	0.000861	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—lung cancer	0.000107	0.00085	CcSEcCtD
Prasugrel—Dizziness—Etoposide—lung cancer	0.000107	0.000848	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—lung cancer	0.000107	0.000846	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—lung cancer	0.000107	0.000844	CcSEcCtD
Prasugrel—Body temperature increased—Docetaxel—lung cancer	0.000106	0.000843	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—lung cancer	0.000106	0.000843	CcSEcCtD
Prasugrel—Dizziness—Paclitaxel—lung cancer	0.000105	0.000832	CcSEcCtD
Prasugrel—Nausea—Cisplatin—lung cancer	0.000105	0.000832	CcSEcCtD
Prasugrel—Cough—Methotrexate—lung cancer	0.000104	0.000822	CcSEcCtD
Prasugrel—Rash—Etoposide—lung cancer	0.000102	0.000809	CcSEcCtD
Prasugrel—Dermatitis—Etoposide—lung cancer	0.000102	0.000808	CcSEcCtD
Prasugrel—Headache—Etoposide—lung cancer	0.000101	0.000804	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.0001	0.000796	CcSEcCtD
Prasugrel—Rash—Paclitaxel—lung cancer	0.0001	0.000793	CcSEcCtD
Prasugrel—Dermatitis—Paclitaxel—lung cancer	0.0001	0.000792	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—lung cancer	9.96e-05	0.000789	CcSEcCtD
Prasugrel—Headache—Paclitaxel—lung cancer	9.95e-05	0.000788	CcSEcCtD
Prasugrel—Hypersensitivity—Docetaxel—lung cancer	9.92e-05	0.000785	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—lung cancer	9.7e-05	0.000768	CcSEcCtD
Prasugrel—Asthenia—Docetaxel—lung cancer	9.66e-05	0.000765	CcSEcCtD
Prasugrel—Nausea—Etoposide—lung cancer	9.62e-05	0.000762	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—lung cancer	9.51e-05	0.000754	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—lung cancer	9.5e-05	0.000752	CcSEcCtD
Prasugrel—Nausea—Paclitaxel—lung cancer	9.43e-05	0.000747	CcSEcCtD
Prasugrel—Skin disorder—Methotrexate—lung cancer	9.42e-05	0.000746	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—lung cancer	9.21e-05	0.00073	CcSEcCtD
Prasugrel—Diarrhoea—Docetaxel—lung cancer	9.21e-05	0.000729	CcSEcCtD
Prasugrel—Hypotension—Methotrexate—lung cancer	9.06e-05	0.000718	CcSEcCtD
Prasugrel—Cough—Doxorubicin—lung cancer	8.98e-05	0.000711	CcSEcCtD
Prasugrel—Dizziness—Docetaxel—lung cancer	8.9e-05	0.000705	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—lung cancer	8.89e-05	0.000704	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.7e-05	0.000689	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—lung cancer	8.65e-05	0.000685	CcSEcCtD
Prasugrel—Rash—Docetaxel—lung cancer	8.49e-05	0.000672	CcSEcCtD
Prasugrel—Dermatitis—Docetaxel—lung cancer	8.48e-05	0.000672	CcSEcCtD
Prasugrel—Headache—Docetaxel—lung cancer	8.43e-05	0.000668	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—lung cancer	8.4e-05	0.000665	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—lung cancer	8.37e-05	0.000663	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—lung cancer	8.36e-05	0.000662	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—lung cancer	8.22e-05	0.000651	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—lung cancer	8.16e-05	0.000646	CcSEcCtD
Prasugrel—Nausea—Docetaxel—lung cancer	7.99e-05	0.000633	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—lung cancer	7.85e-05	0.000622	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—lung cancer	7.67e-05	0.000607	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—lung cancer	7.49e-05	0.000593	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—lung cancer	7.25e-05	0.000574	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—lung cancer	7.24e-05	0.000574	CcSEcCtD
Prasugrel—Hypersensitivity—Methotrexate—lung cancer	7.15e-05	0.000566	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—lung cancer	6.96e-05	0.000551	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—lung cancer	6.64e-05	0.000526	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—lung cancer	6.64e-05	0.000526	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—lung cancer	6.41e-05	0.000508	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—lung cancer	6.19e-05	0.00049	CcSEcCtD
Prasugrel—Rash—Methotrexate—lung cancer	6.12e-05	0.000484	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—lung cancer	6.11e-05	0.000484	CcSEcCtD
Prasugrel—Headache—Methotrexate—lung cancer	6.08e-05	0.000481	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—lung cancer	6.03e-05	0.000477	CcSEcCtD
Prasugrel—Nausea—Methotrexate—lung cancer	5.76e-05	0.000456	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—lung cancer	5.75e-05	0.000455	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—lung cancer	5.55e-05	0.00044	CcSEcCtD
Prasugrel—Rash—Doxorubicin—lung cancer	5.3e-05	0.00042	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—lung cancer	5.29e-05	0.000419	CcSEcCtD
Prasugrel—Headache—Doxorubicin—lung cancer	5.26e-05	0.000417	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—lung cancer	4.99e-05	0.000395	CcSEcCtD
Prasugrel—CYP2B6—Metabolism—ENO1—lung cancer	1.12e-05	0.000111	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.11e-05	0.000111	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTA2—lung cancer	1.11e-05	0.000111	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.11e-05	0.00011	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—lung cancer	1.1e-05	0.000109	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—JUN—lung cancer	1.09e-05	0.000109	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—UGT1A1—lung cancer	1.09e-05	0.000109	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CREBBP—lung cancer	1.08e-05	0.000108	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NCOA3—lung cancer	1.08e-05	0.000108	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CKB—lung cancer	1.08e-05	0.000108	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTA1—lung cancer	1.07e-05	0.000107	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.06e-05	0.000106	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—lung cancer	1.06e-05	0.000106	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1A—lung cancer	1.06e-05	0.000106	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.06e-05	0.000106	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCC3—lung cancer	1.06e-05	0.000105	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTEN—lung cancer	1.06e-05	0.000105	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ADCY1—lung cancer	1.05e-05	0.000105	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCG2—lung cancer	1.05e-05	0.000105	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNG11—lung cancer	1.05e-05	0.000105	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.05e-05	0.000104	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HPGDS—lung cancer	1.03e-05	0.000103	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ENO2—lung cancer	1.03e-05	0.000103	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—lung cancer	1.03e-05	0.000103	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CD—lung cancer	1.03e-05	0.000102	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPP2R1B—lung cancer	1.03e-05	0.000102	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKR1C1—lung cancer	1.02e-05	0.000102	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM2—lung cancer	1.02e-05	0.000101	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CNDP2—lung cancer	1.02e-05	0.000101	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.01e-05	0.000101	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EP300—lung cancer	1.01e-05	0.0001	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTT1—lung cancer	1e-05	9.99e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALDOA—lung cancer	1e-05	9.98e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP2E1—lung cancer	1e-05	9.97e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—UGT1A1—lung cancer	9.95e-06	9.91e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2A6—lung cancer	9.91e-06	9.87e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GCLC—lung cancer	9.91e-06	9.87e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTMR3—lung cancer	9.91e-06	9.87e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NQO1—lung cancer	9.9e-06	9.86e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.87e-06	9.83e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SRC—lung cancer	9.81e-06	9.77e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NCOA3—lung cancer	9.73e-06	9.69e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PGAM1—lung cancer	9.65e-06	9.62e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNG11—lung cancer	9.59e-06	9.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.56e-06	9.52e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—lung cancer	9.55e-06	9.52e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.55e-06	9.51e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ADCY1—lung cancer	9.46e-06	9.43e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCG2—lung cancer	9.46e-06	9.43e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—lung cancer	9.46e-06	9.42e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NRAS—lung cancer	9.44e-06	9.4e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ENO1—lung cancer	9.39e-06	9.36e-05	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	9.39e-06	9.35e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.36e-06	9.32e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ENO2—lung cancer	9.28e-06	9.24e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HPGDS—lung cancer	9.28e-06	9.24e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPP2R1B—lung cancer	9.22e-06	9.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2A7—lung cancer	9.21e-06	9.18e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAF1—lung cancer	9.18e-06	9.14e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALDOA—lung cancer	9.13e-06	9.1e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.1e-06	9.06e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK3—lung cancer	9.04e-06	9e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SDC4—lung cancer	9.01e-06	8.98e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTT1—lung cancer	9e-06	8.97e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CB—lung cancer	8.96e-06	8.93e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—STK11—lung cancer	8.92e-06	8.89e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GCLC—lung cancer	8.9e-06	8.86e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2A6—lung cancer	8.9e-06	8.86e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NCOA3—lung cancer	8.87e-06	8.84e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.86e-06	8.83e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—lung cancer	8.79e-06	8.76e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.71e-06	8.68e-05	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	8.66e-06	8.63e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ADCY1—lung cancer	8.63e-06	8.59e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCG2—lung cancer	8.63e-06	8.59e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—lung cancer	8.6e-06	8.56e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ENO2—lung cancer	8.46e-06	8.43e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HPGDS—lung cancer	8.46e-06	8.43e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ENO1—lung cancer	8.43e-06	8.4e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2E1—lung cancer	8.43e-06	8.39e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPP2R1B—lung cancer	8.41e-06	8.38e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.4e-06	8.37e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NQO1—lung cancer	8.33e-06	8.3e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.29e-06	8.26e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.29e-06	8.26e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTP1—lung cancer	8.25e-06	8.22e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—lung cancer	8.23e-06	8.2e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—RRM1—lung cancer	8.21e-06	8.18e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA3—lung cancer	8.21e-06	8.18e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTT1—lung cancer	8.21e-06	8.18e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.16e-06	8.13e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—lung cancer	8.12e-06	8.09e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GCLC—lung cancer	8.11e-06	8.08e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2A6—lung cancer	8.11e-06	8.08e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.08e-06	8.05e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.08e-06	8.05e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAT—lung cancer	8.03e-06	8e-05	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.94e-06	7.92e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ABCB1—lung cancer	7.81e-06	7.78e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—B4GALT5—lung cancer	7.72e-06	7.69e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ENO1—lung cancer	7.69e-06	7.66e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TYMS—lung cancer	7.67e-06	7.65e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.66e-06	7.63e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—lung cancer	7.59e-06	7.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2E1—lung cancer	7.56e-06	7.54e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.56e-06	7.53e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—STK11—lung cancer	7.51e-06	7.48e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA4—lung cancer	7.51e-06	7.48e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NQO1—lung cancer	7.48e-06	7.45e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—lung cancer	7.46e-06	7.43e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—EP300—lung cancer	7.38e-06	7.36e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.32e-06	7.3e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA2—lung cancer	7.32e-06	7.29e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.26e-06	7.23e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—lung cancer	7.22e-06	7.19e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A1—lung cancer	7.19e-06	7.16e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SRC—lung cancer	7.18e-06	7.15e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ERCC2—lung cancer	7.13e-06	7.11e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA1—lung cancer	7.06e-06	7.03e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.05e-06	7.02e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—lung cancer	6.99e-06	6.97e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCC3—lung cancer	6.98e-06	6.95e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTP1—lung cancer	6.95e-06	6.92e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NRAS—lung cancer	6.91e-06	6.88e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HRAS—lung cancer	6.9e-06	6.88e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2E1—lung cancer	6.9e-06	6.87e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NQO1—lung cancer	6.82e-06	6.79e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAT—lung cancer	6.76e-06	6.74e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKR1C1—lung cancer	6.76e-06	6.73e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—STK11—lung cancer	6.74e-06	6.72e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.72e-06	6.7e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.68e-06	6.65e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.62e-06	6.59e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK3—lung cancer	6.62e-06	6.59e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—lung cancer	6.61e-06	6.58e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCB1—lung cancer	6.58e-06	6.55e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—UGT1A1—lung cancer	6.56e-06	6.54e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TYMS—lung cancer	6.46e-06	6.44e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—lung cancer	6.39e-06	6.36e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.33e-06	6.3e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNG11—lung cancer	6.33e-06	6.3e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTP1—lung cancer	6.24e-06	6.21e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOA1—lung cancer	6.17e-06	6.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—STK11—lung cancer	6.15e-06	6.12e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—lung cancer	6.09e-06	6.07e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAT—lung cancer	6.07e-06	6.05e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A1—lung cancer	6.05e-06	6.03e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.03e-06	6.01e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDOA—lung cancer	6.02e-06	6e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ERCC2—lung cancer	6e-06	5.98e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—lung cancer	5.95e-06	5.92e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCB1—lung cancer	5.9e-06	5.88e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOA3—lung cancer	5.85e-06	5.83e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TYMS—lung cancer	5.8e-06	5.78e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.77e-06	5.75e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—lung cancer	5.73e-06	5.71e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADCY1—lung cancer	5.69e-06	5.67e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCG2—lung cancer	5.69e-06	5.67e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTP1—lung cancer	5.69e-06	5.67e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—lung cancer	5.63e-06	5.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ENO2—lung cancer	5.58e-06	5.56e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HPGDS—lung cancer	5.58e-06	5.56e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.54e-06	5.52e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAT—lung cancer	5.53e-06	5.51e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.5e-06	5.48e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—lung cancer	5.46e-06	5.44e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A1—lung cancer	5.43e-06	5.41e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTT1—lung cancer	5.41e-06	5.39e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ERCC2—lung cancer	5.39e-06	5.37e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCB1—lung cancer	5.38e-06	5.36e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—POMC—lung cancer	5.36e-06	5.34e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2A6—lung cancer	5.35e-06	5.33e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GCLC—lung cancer	5.35e-06	5.33e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TYMS—lung cancer	5.29e-06	5.27e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—lung cancer	5.28e-06	5.26e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—lung cancer	5.23e-06	5.21e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CREBBP—lung cancer	5.22e-06	5.2e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOA1—lung cancer	5.19e-06	5.17e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ENO1—lung cancer	5.07e-06	5.05e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HRAS—lung cancer	5.05e-06	5.04e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.97e-06	4.95e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A1—lung cancer	4.95e-06	4.94e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CD—lung cancer	4.95e-06	4.93e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ERCC2—lung cancer	4.91e-06	4.9e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—lung cancer	4.89e-06	4.87e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—lung cancer	4.74e-06	4.72e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOA1—lung cancer	4.66e-06	4.64e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2E1—lung cancer	4.55e-06	4.53e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—POMC—lung cancer	4.51e-06	4.5e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NQO1—lung cancer	4.5e-06	4.48e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.46e-06	4.45e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—lung cancer	4.46e-06	4.45e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CREBBP—lung cancer	4.4e-06	4.38e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CB—lung cancer	4.32e-06	4.3e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—lung cancer	4.28e-06	4.26e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—lung cancer	4.26e-06	4.24e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOA1—lung cancer	4.25e-06	4.24e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CD—lung cancer	4.17e-06	4.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.07e-06	4.06e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—STK11—lung cancer	4.05e-06	4.04e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—POMC—lung cancer	4.05e-06	4.04e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CREBBP—lung cancer	3.95e-06	3.93e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—lung cancer	3.88e-06	3.87e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTP1—lung cancer	3.75e-06	3.74e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CD—lung cancer	3.74e-06	3.73e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTEN—lung cancer	3.73e-06	3.72e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—POMC—lung cancer	3.69e-06	3.68e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—lung cancer	3.69e-06	3.68e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAT—lung cancer	3.65e-06	3.64e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CB—lung cancer	3.63e-06	3.62e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—lung cancer	3.6e-06	3.59e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CREBBP—lung cancer	3.6e-06	3.58e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—EP300—lung cancer	3.56e-06	3.54e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCB1—lung cancer	3.55e-06	3.54e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TYMS—lung cancer	3.49e-06	3.47e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—lung cancer	3.45e-06	3.43e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CD—lung cancer	3.41e-06	3.4e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—lung cancer	3.37e-06	3.36e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A1—lung cancer	3.27e-06	3.26e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CB—lung cancer	3.26e-06	3.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ERCC2—lung cancer	3.24e-06	3.23e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—lung cancer	3.23e-06	3.22e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTEN—lung cancer	3.14e-06	3.13e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—EP300—lung cancer	2.99e-06	2.98e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CB—lung cancer	2.97e-06	2.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—lung cancer	2.95e-06	2.94e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTEN—lung cancer	2.82e-06	2.81e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOA1—lung cancer	2.8e-06	2.79e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—EP300—lung cancer	2.69e-06	2.68e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—lung cancer	2.63e-06	2.62e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTEN—lung cancer	2.57e-06	2.56e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—lung cancer	2.56e-06	2.55e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—EP300—lung cancer	2.45e-06	2.44e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—POMC—lung cancer	2.44e-06	2.43e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CREBBP—lung cancer	2.37e-06	2.36e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CD—lung cancer	2.25e-06	2.24e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—lung cancer	2.22e-06	2.21e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—lung cancer	2.21e-06	2.21e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—lung cancer	2.15e-06	2.14e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—lung cancer	1.99e-06	1.98e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CB—lung cancer	1.96e-06	1.95e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—lung cancer	1.94e-06	1.94e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—lung cancer	1.81e-06	1.81e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—lung cancer	1.81e-06	1.8e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTEN—lung cancer	1.69e-06	1.69e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—lung cancer	1.62e-06	1.62e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—EP300—lung cancer	1.62e-06	1.61e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—lung cancer	1.48e-06	1.48e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—lung cancer	1.2e-06	1.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—lung cancer	9.77e-07	9.73e-06	CbGpPWpGaD
